Table 1.
Characteristics of stroke patients according to functional outcomes
| Total | Good outcomes | Poor outcomes | P | |
|---|---|---|---|---|
| N | 209 | 157 | 52 | - |
| Age, years median (IQR) | 66 (55-75) | 63 (52-71) | 72 (60-81) | 0.012 |
| Female gender, n (%) | 83 (39.7) | 60 (38.2) | 23 (44.2) | 0.44 |
| BMI, kg/m2 median (IQR) | 24.5 (23.1-26.8) | 24.1 (22.5-26.1) | 26.1 (24.2-28.5) | 0.018 |
| Smoking, n (%) | 64 (30.6) | 46 (29.3) | 18 (34.6) | 0.47 |
| Drinking, n (%) | 52 (24.9) | 42 (26.8) | 10 (19.2) | 0.28 |
| SBP, mmHg median (IQR) | 148 (130-169) | 142 (125-163) | 160 (139-181) | 0.007 |
| DBP, mmHg median (IQR) | 80 (72-95) | 77 (70-90) | 88 (77-100) | 0.011 |
| Prior vascular risk factors, n (%) | ||||
| Hypertension | 136 (65.1) | 100 (63.7) | 36 (69.2) | 0.48 |
| Hypercholesterolemia | 71 (34.0) | 51 (32.5) | 20 (38.5) | 0.38 |
| Atrial fibrillation | 25 (12.0) | 19 (12.1) | 6 (11.5) | 0.91 |
| Myocardial infarction | 24 (11.5) | 16 (10.2) | 8 (15.4) | 0.31 |
| Previous TIA | 18 (8.6) | 10 (6.4) | 8 (15.4) | 0.045 |
| Pre-stroke treatment, n (%) | ||||
| Antihypertensive treatment | 142 (67.9) | 105 (66.9) | 37 (71.2) | 0.57 |
| Antiplatelet agents | 63 (30.1) | 49 (31.2) | 14 (26.9) | 0.56 |
| Acute treatment, n (%) | ||||
| IV thrombolysis | 27 (12.9) | 25 (15.9) | 2 (3.8) | 0.024 |
| Mechanical thrombectomy | 18 (8.6) | 16 (10.2) | 2 (3.8) | 0.26 |
| Stroke etiology, n (%) | ||||
| Small-vessel occlusive | 39 (18.7) | 28 (17.8) | 11 (21.1) | 0.59 |
| Large-vessel occlusive | 45 (21.5) | 29 (18.5) | 16 (30.8) | 0.061 |
| Cardioembolic | 78 (37.3) | 60 (38.2) | 18 (34.6) | 0.64 |
| Other | 21 (10.0) | 18 (11.5) | 3 (5.8) | 0.24 |
| Unknown | 26 (12.5) | 22 (14.0) | 4 (7.7) | 0.23 |
| NIHSS at admission, median (IQR) | 7 (4-12) | 6 (4-11) | 9 (5-15) | <0.001 |
| Lesion volumes, ml median (IQR) | 18.6 (10.2-31.3) | 17.3 (9.6-29.4) | 20.5 (12.7-36.9) | 0.002 |
| Time from onset to admission, hours | 14.0 (10.5-18.5) | 13.5 (10.0-18.0) | 15.0 (11.5-20.0) | 0.07 |
| Laboratory findings, medians (IQR) | ||||
| Glucose level, mmol/L | 5.22 (4.93-5.92) | 5.03 (4.88-5.77) | 5.55 (5.10-6.03) | 0.015 |
| CRP, mg/l | 6.33 (4.13-9.76) | 5.95 (3.88-8.94) | 6.99 (4.55-10.39) | 0.009 |
| IL-6, pg/ml | 7.55 (5.14-10.33) | 7.12 (5.00-9.55) | 8.32 (5.94-12.10) | 0.006 |
| Omentin-1, ng/ml | 129.0 (97.1-163.7) | 137.6 (106.1-171.5) | 100.8 (80.9-131.6) | <0.001 |
SBP, Systolic blood pressure; DBP, Diastolic blood pressure; NIHSS, National Institutes of Health Stroke Scale; TIA, transient ischemic attack; IL-6, interleukin-6; IQR, interquartile ranges.